×
News Home

Is One World Pharma Inc (OWPC) a Loser in the Healthcare Sector?

Wednesday, September 08, 2021 01:43 PM | InvestorsObserver Analysts
Is One World Pharma Inc (OWPC) a Loser in the Healthcare Sector?

One World Pharma Inc (OWPC) is around the bottom of the Healthcare sector according to InvestorsObserver. OWPC received an overall rating of 20, which means that it scores higher than 20% of stocks. Additionally, One World Pharma Inc scored a 12 in the Healthcare sector, ranking it higher than 12% of stocks in that sector.

Overall Score - 20
OWPC has an Overall Score of 20. Find out what this means to you and get the rest of the rankings on OWPC!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 20 means the stock is more attractive than 20 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With One World Pharma Inc Stock Today?

One World Pharma Inc (OWPC) stock is trading at $0.12 as of 1:24 PM on Wednesday, Sep 8, a drop of -$0.03, or -19.7% from the previous closing price of $0.15. The stock has traded between $0.12 and $0.15 so far today. Volume today is above average. So far 150,264 shares have traded compared to average volume of 83,793 shares. Click Here to get the full Stock Report for One World Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App